Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: Imaging predictors of overall and progression-free survival

Neuro-Oncology

Volumn 17, Issue 11, 2015, Pages 1525-1537

  Wangaryattawanich, Pattana ^a,b   Hatami, Masumeh ^a   Wang, Jixin ^a   Thomas, Ginu ^a   Flanders, Adam ^c   Kirby, Justin ^d   Wintermark, Max ^e   Huang, Erich S ^f   Bakhtiari, Ali Shojaee ^a   Luedi, Markus M ^a   Hashmi, Syed S ^g   Rubin, Daniel L ^e   Chen, James Y ^h   Hwang, Scott N ⁱ   Freymann, John ^d   Holder, Chad A ^j   Zinn, Pascal O ^a,k   Colen, Rivka R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^e STANFORD UNIVERSITY   (United States)

^f SAGE BIONETWORKS   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

glioblastoma; imaging; overall survival; progression free survival; TCGA

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL GANGLION; BLEEDING; BRAIN STEM; CANCER MORTALITY; CEREBELLUM; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; CORRELATION ANALYSIS; DIFFUSION; EDEMA; FEMALE; FRONTAL LOBE; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; INSULA; MAJOR CLINICAL STUDY; MALE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OVERALL SURVIVAL; PARIETAL LOBE; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; TEMPORAL LOBE; THALAMUS; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME; WHITE MATTER; AREA UNDER THE CURVE; BRAIN TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; DISEASE FREE SURVIVAL; FACTUAL DATABASE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEUROIMAGING; PATHOLOGY; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BRAIN NEOPLASMS; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84946574783     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov117     Document Type: Article

References (43)

1. Central Brain Tumor Registery of the United States. CBTRUS Statistical Report: Primary Brain and Central Nervous Tumors Diagnosed in the United States in 2004-2008. Hinsdale, IL: CBTRUS; 2012.
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
3. Gehan EA, Walker MD. Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr. 1977;46:189-195.
4. Scott GM, Gibberd FB. Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand. 1980;61(4):227-239.
5. Gilbert H, Kagan AR, Cassidy F, et al. Glioblastoma multiforme is not a uniform disease! Cancer Clin Trials. 1981;4(1):87-89.
6. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 1987; 59(9):1617-1625.
7. Kowalczuk A, Macdonald RL, Amidei C, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery. 1997;41(5):1028-1036; discussion 1036-1038.
8. Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol. 1999;42(3):227-231.
9. Kreth FW, Berlis A, Spiropoulou V, et al. The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer. 1999;86(10):2117-2123.
10. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-198.
11. Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62(3):564-576;discussion 564-576.
12. Chaichana KL, Chaichana KK, Olivi A, et al. Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg. 2011;114(3):587-594.
13. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003.
14. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765-773.
15. Belden CJ, Valdes PA, Ran C, et al. Genetics of glioblastoma: a window into its imaging and histopathologic variability. Radiographics. 2011;31(6):1717-1740.
16. Iliadis G, Kotoula V, Chatzisotiriou A, et al. Volumetric and MGMT parameters in glioblastoma patients: survival analysis. BMC Cancer. 2012;12:3.
17. Aghi M, Gaviani P, Henson JW, et al. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma. Clin Cancer Res. 2005;11(24 Pt 1):8600-8605.
18. Andreou J, George AE, Wise A, et al. CT prognostic criteria of survival after malignant glioma surgery. AJNR Am J Neuroradiol. 1983;4(3):488-490.
19. Hammoud MA, Sawaya R, Shi W, et al. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol. 1996;27(1):65-73.
20. Steltzer KJ, Sauve KI, Spence AM, et al. Corpus callosum involvement as a prognostic factor for patients with high-grade astrocytoma. Int J Radiat Oncol Biol Phys. 1997;38(1):27-30.
21. Pope WB, Sayre J, Perlina A, et al. MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005; 26(10):2466-2474.
22. Schoenegger K, Oberndorfer S, Wuschitz B, et al. Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? Eur J Neurol. 2009;16(7):874-878.
23. Ramakrishna R, Barber J, Kennedy G, et al. Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: correlation with survival. Surg Neurol Int. 2010;1:40.
24. Ekici MA, Bulut T, Tucer B, et al. Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas. Turk Neurosurg. 2011;21(3):271-279.
25. Kaur G, Bloch O, Jian BJ, et al. A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival. J Neurosurg. 2011;115(4):754-759.
26. Gutman DA, Cooper LA, Hwang SN, et al. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology. 2013;267(2):560-569.
27. Jain R, Poisson L, Narang J, et al. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology. 2013;267(1):212-220.
28. Mazurowski MA, Desjardins A, Malof JM. Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro Oncol. 2013;15(10):1389-1394.
29. Cordova JS, Schreibmann E, Hadjipanayis CG, et al. Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials. Transl Oncol. 2014; 7(1):40-47.
30. Nicolasjilwan M, Hu Y, Yan C, et al. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. J Neuroradiol. 2015;42(4):212-221.
31. Cancer Genome Atlas Research N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
32. Clark K, Vendt B, Smith K, et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26(6):1045-1057.
33. Visually Accessible Rembrandt Images (VASARI) feature set for human glioma. September 11, 2014.
34. Zinn PO, Mahajan B, Sathyan P, et al. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PloS One. 2011;6(10):e25451.
35. Gering DT, Nabavi A, Kikinis R, et al. An integrated visualization system for surgical planning and guidance using image fusion and an open MR. J Magn Reson Imaging. 2001;13(6): 967-975.
36. Pichon E, Tannenbaum A, Kikinis R. A statistically based flow for image segmentation. Med Image Anal. 2004;8(3):267-274.
37. Archip N, Jolesz FA, Warfield SK. A validation framework for brain tumor segmentation. Acad Radiol. 2007;14(10):1242-1251.
38. Colen RR, Wang J, Singh SK, et al. Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. Radiology. 2015;275(1):215-227.
39. Thomas RP, Xu LW, Lober RM, et al. The incidence and significance of multiple lesions in glioblastoma. J Neurooncol. 2013;112(1): 91-97.
40. Paulsson AK, Holmes JA, Peiffer AM, et al. Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol. 2014;119(2):429-435.
41. Chaddad A, Colen RR. Statistical feature selection for enhanced detection of brain tumor. In: SPIE. Vol 9217: Application of Digital Image Processing XXXVII; 2014.
42. Chaddad A, Zinn PO, Colen RR. Brain tumor identification using Gaussian Mixture Model features and Decision Trees Classification. In: 48th Annual Conference on Information Sciences and Systems (CISS), 2014:1-4.
43. Chaddad A, Zinn PO, Colen RR. Quantitative texture analysis for glioblastoma phenotypes discrimination. IEEE CODIT, Biomedical engineering and clinical application 2014.